![Cancer biomarker discovery for cholangiocarcinoma: the high‐throughput approaches - Silsirivanit - 2014 - Journal of Hepato-Biliary-Pancreatic Sciences - Wiley Online Library Cancer biomarker discovery for cholangiocarcinoma: the high‐throughput approaches - Silsirivanit - 2014 - Journal of Hepato-Biliary-Pancreatic Sciences - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7e1203bd-e141-4117-9d86-7aa272b3f075/jhbp68-fig-0001-m.jpg)
Cancer biomarker discovery for cholangiocarcinoma: the high‐throughput approaches - Silsirivanit - 2014 - Journal of Hepato-Biliary-Pancreatic Sciences - Wiley Online Library
![Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type](https://www.frontiersin.org/files/Articles/318545/fgene-09-00309-HTML/image_m/fgene-09-00309-g001.jpg)
Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type
![Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41575-020-0310-z/MediaObjects/41575_2020_310_Fig8_HTML.png)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
![PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/942919bec9429e21c4d8ed2b634a865a13da7cad/3-Table2-1.png)
PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-17175-7/MediaObjects/41598_2017_17175_Fig1_HTML.jpg)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41575-020-0310-z/MediaObjects/41575_2020_310_Fig4_HTML.png)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
![Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease. | Semantic Scholar Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e47fb9702c40dca3ba4517eedeb8f16eadba2360/4-Table5-1.png)
Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease. | Semantic Scholar
![Frontiers | Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study Frontiers | Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study](https://www.frontiersin.org/files/Articles/829407/fonc-12-829407-HTML-r1/image_m/fonc-12-829407-g001.jpg)
Frontiers | Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study
![Cells | Free Full-Text | Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis Cells | Free Full-Text | Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis](https://www.mdpi.com/cells/cells-09-00721/article_deploy/html/images/cells-09-00721-g010.png)